McCarran Consulting advises biotechnology, pharmaceutical, consumer-health and animal-health companies on drug product development and CMC strategy—from early formulation through commercial manufacturing.
Engagements combine engineering rigor, hands-on development experience and a clear view of the business consequences of technical decisions.
• CMC and drug product development strategy
• Formulation and process development
• Scale-up, technology transfer and process validation
• CDMO selection, oversight and technical problem solving
• Technical due diligence and CMC risk assessment
• Regulatory CMC and practical remediation
